Array Biopharma Incis A Biopharmaceutical Company Based In Bouldercoloradofounded In 1998The Company Specializes In The Discoverydevelopmentand Commercialization Of Targeted Small Molecule Drugsprimarily Aimed At Treating Cancer And Inflammatory Diseasesarray Biopharma Utilizes A Proprietary Drug Discovery Platform That Integrates Chemistrybiologyand Informatics To Create New Drugscollaborating With Leading Pharmaceutical And Biotechnology Companies To Enhance Its Drug Development Efforts The Company S Portfolio Includes Clinical Candidates Like Braftoviwhich Is Approved For Use In Treating Specific Cancersarray Biopharma Focuses On Developing Targeted Therapies That Aim To Improve Treatment Efficacy And Safetyin 2019The Company Was Acquired By Pfizer Incfor Approximately $11 4 Billionhighlighting The Significance Of Its Innovative Drug Development Approach And Its Valuable Portfolio Of Targeted Small Molecule Medicines
